title: A genomic strategy for the functional validation of colorectal cancer genes identifies potential therapeutic targets.
abstract: Genes that are highly overexpressed in tumor cells can be required for tumor cell survival and have the potential to be selective therapeutic targets. In an attempt to identify such targets, we combined a functional genomics and a systems biology approach to assess the consequences of RNAi-mediated silencing of overexpressed genes that were selected from 140 gene expression profiles from colorectal cancers (CRCs) and matched normal mucosa. In order to identify credible models for in-depth functional analysis, we first confirmed the overexpression of these genes in 25 different CRC cell lines. We then identified five candidate genes that profoundly reduced the viability of CRC cell lines when silenced with either siRNAs or short-hairpin RNAs (shRNAs), i.e., HMGA1, TACSTD2, RRM2, RPS2 and NOL5A. These genes were further studied by systematic analysis of comprehensive gene expression profiles generated following siRNA-mediated silencing. Exploration of these RNAi-specific gene expression signatures allowed the identification of the functional space in which the five genes operate and showed enrichment for cancer-specific signaling pathways, some known to be involved in CRC. By comparing the expression of the RNAi signature genes with their respective expression levels in an independent set of primary rectal carcinomas, we could recapitulate these defined RNAi signatures, therefore, establishing the biological relevance of our observations. This strategy identified the signaling pathways that are affected by the prominent oncogenes HMGA1 and TACSTD2, established a yet unknown link between RRM2 and PLK1 and identified RPS2 and NOL5A as promising potential therapeutic targets in CRC.
authors.affiliation: Department of General and Visceral Surgery, University Medicine Göttingen, Georg-August-University, Göttingen, Germany.
authors.forename: Marian
authors.initials: M
authors.lastname: Grade
authors.forename: Amanda B
authors.initials: AB
authors.lastname: Hummon
authors.forename: Jordi
authors.initials: J
authors.lastname: Camps
authors.forename: Georg
authors.initials: G
authors.lastname: Emons
authors.forename: Melanie
authors.initials: M
authors.lastname: Spitzner
authors.forename: Jochen
authors.initials: J
authors.lastname: Gaedcke
authors.forename: Patrick
authors.initials: P
authors.lastname: Hoermann
authors.forename: Reinhard
authors.initials: R
authors.lastname: Ebner
authors.forename: Heinz
authors.initials: H
authors.lastname: Becker
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Difilippantonio
authors.forename: B Michael
authors.initials: BM
authors.lastname: Ghadimi
authors.forename: Tim
authors.initials: T
authors.lastname: Beissbarth
authors.forename: Natasha J
authors.initials: NJ
authors.lastname: Caplen
authors.forename: Thomas
authors.initials: T
authors.lastname: Ried
mesh_terms: D045744:Cell Line, Tumor; D015179:Colorectal Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy; D020869:Gene Expression Profiling; D020868:Gene Silencing; D023281:Genomics; D006801:Humans; D007150:Immunohistochemistry; D034622:RNA Interference
references.citation: Cancer Res. 2005 Jul 15;65(14):6139-50
references.pmid: 16024615
references.citation: Cancer Res. 2007 Jan 1;67(1):41-56
references.pmid: 17210682
references.citation: Int J Cancer. 1995 Sep 4;62(5):610-8
references.pmid: 7665234
references.citation: Genes Dev. 2004 Mar 1;18(5):504-11
references.pmid: 15014042
references.citation: Genes Dev. 2006 Mar 1;20(5):515-24
references.pmid: 16510870
references.citation: Biochem J. 2005 Feb 15;386(Pt 1):85-91
references.pmid: 15473865
references.citation: Annu Rev Biochem. 2006;75:681-706
references.pmid: 16756507
references.citation: J Exp Clin Cancer Res. 2009 Jan 12;28:6
references.pmid: 19138403
references.citation: Mol Cell Biol. 2004 Sep;24(18):7829-40
references.pmid: 15340047
references.citation: PLoS Genet. 2008 Jun 06;4(6):e1000090
references.pmid: 18535662
references.citation: Nat Rev Cancer. 2006 Apr;6(4):321-30
references.pmid: 16557283
references.citation: Acta Biochim Pol. 2002;49(3):615-24
references.pmid: 12422231
references.citation: Expert Rev Anticancer Ther. 2004 Apr;4(2):289-302
references.pmid: 15056059
references.citation: Nat Rev Cancer. 2008 Dec;8(12):976-90
references.pmid: 19029958
references.citation: FEBS Lett. 2006 Jun 26;580(15):3694-8
references.pmid: 16764866
references.citation: Bioinformatics. 2008 Nov 15;24(22):2650-6
references.pmid: 18227117
references.citation: PLoS Comput Biol. 2007 Apr 6;3(4):e63
references.pmid: 17411336
references.citation: Int J Oncol. 2008 Feb;32(2):289-305
references.pmid: 18202751
references.citation: Cancer Res. 2000 Jun 1;60(11):2764-9
references.pmid: 10850410
references.citation: BMC Bioinformatics. 2007 May 22;8:166
references.pmid: 17519018
references.citation: Nature. 2006 Jan 19;439(7074):353-7
references.pmid: 16273092
references.citation: Mol Cancer Ther. 2008 Feb;7(2):280-5
references.pmid: 18281513
references.citation: Clin Cancer Res. 2005 Apr 1;11(7):2612-9
references.pmid: 15814641
references.citation: EMBO J. 2002 Oct 1;21(19):5088-96
references.pmid: 12356725
references.citation: Genes Chromosomes Cancer. 2009 Nov;48(11):1002-17
references.pmid: 19691111
references.citation: RNA. 2006 Jun;12(6):988-93
references.pmid: 16611941
references.citation: Int J Cancer. 2009 Mar 1;124(5):1081-9
references.pmid: 19048623
references.citation: Biotechnol Bioeng. 2007 Jul 1;97(4):909-21
references.pmid: 17154307
references.citation: Clin Cancer Res. 2007 Apr 1;13(7):2207-15
references.pmid: 17404105
references.citation: PLoS One. 2009 Jul 03;4(7):e6146
references.pmid: 19582160
references.citation: Methods Mol Biol. 2007;377:203-22
references.pmid: 17634619
references.citation: RNA. 2006 Jul;12(7):1179-87
references.pmid: 16682560
references.citation: Nat Med. 2006 Nov;12(11):1294-300
references.pmid: 17057710
references.citation: Proc Natl Acad Sci U S A. 2001 Jul 3;98(14):8012-7
references.pmid: 11416159
references.citation: Cell Cycle. 2007 Jan 15;6(2):205-17
references.pmid: 17314511
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20882-7
references.pmid: 19088204
references.citation: Oncogene. 2008 Dec 4;27(57):7192-200
references.pmid: 18806828
references.citation: Bioinformatics. 2008 Nov 1;24(21):2549-50
references.pmid: 18718939
references.citation: Int J Cancer. 1998 May 29;76(5):671-6
references.pmid: 9610724
references.citation: Cancer Res. 2006 Jan 1;66(1):267-82
references.pmid: 16397240
references.citation: Nucleic Acids Res. 2007;35(8):e57
references.pmid: 17392344
references.citation: Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18721-6
references.pmid: 17130448
references.citation: Mol Cell Proteomics. 2007 Dec;6(12):2072-87
references.pmid: 17855441
references.citation: Nat Cell Biol. 2003 Sep;5(9):834-9
references.pmid: 12942087
references.citation: Nat Rev Cancer. 2007 Dec;7(12):899-910
references.pmid: 18004397
references.citation: J Biol Chem. 2003 Sep 5;278(36):34309-19
references.pmid: 12777385